W4275

Overview

W4275 (Compound 42) is a selective NSD2 inhibitor with oral activity, showing an IC 50 value of 17 nM. W4275 exhibits antiproliferative activity with an IC 50 of 230 nM against RS411 cells and significantly inhibits tumor growth in the RS411 tumor xenograft model. Pharmacokinetic analysis in mice demonstrates that W4275 has good oral bioavailability ( F of 27.34%). W4275 holds promise for use in cancer research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Histone Methyltransferase

Product Information

• Catalog No.: HY-168035
• CAS No.: 3051650-00-8
• Molecular Formula: C25H36N6O3
• Molecular Weight: 468.59
• Purity: 98.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 6.25 mg/mL (13.34 mM); Clear solution
• Availability: In-stock

Source

Original product source